Work

Combination regimen of intravesical docetaxel, gemcitabine, and cisplatin in patients with BCG-unresponsive bladder cancer: clinical outcomes and genomic correlations

Year: 2025

Type: article

Source: Urologic Oncology Seminars and Original Investigations

DOI: 10.1016/j.urolonc.2025.05.012

Authors: Benjamin I. Joffe, John R. Christin, Clémentine Le Coz, Prakash Gorroochurn, Jamie S. Pak, Caroline Laplaca, Helena Vila Reyes, G. Joel DeCastro, Christopher B. Anderson, Cory Abate-Shen, Michael M. Shen, James M. McKiernan, Andrew T. Lenis

Institutions: Columbia University, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Mark Foundation For Cancer Research, National Institutes of Health, National Cancer Institute

Awards: Epigenetic regulators of subtype plasticity in bladder cancer, G2529041226, G3901782128

OpenAlex ID: W4411112384

FWCI:

Cites: 31

Cited by:

Related to: 10